Ignyte Acquisition (Ignyte Acquisition) Change In Receivables : $0.00 Mil (TTM As of Jun. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Ignyte Acquisition Change In Receivables?

Ignyte Acquisition's change in receivables for the quarter that ended in Jun. 2022 was $0.00 Mil. It means Ignyte Acquisition's Accounts Receivable stayed the same from Mar. 2022 to Jun. 2022 .

Ignyte Acquisition's change in receivables for the fiscal year that ended in Dec. 2021 was $0.00 Mil. It means Ignyte Acquisition's Accounts Receivable stayed the same from Dec. 2020 to Dec. 2021 .

Ignyte Acquisition's Accounts Receivable for the quarter that ended in Jun. 2022 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ignyte Acquisition's liquidation value for the three months ended in Jun. 2022 was $-1.99 Mil.

Ignyte Acquisition Change In Receivables Historical Data

The historical data trend for Ignyte Acquisition's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ignyte Acquisition Change In Receivables Chart

Ignyte Acquisition Annual Data

Trend

Dec20

Dec21

Change In Receivables

Ignyte Acquisition Quarterly Data
	Nov20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Change In Receivables	Get a 7-Day Free Trial			-	-	-	-	-

Ignyte Acquisition Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Ignyte Acquisition (NAS:IGNY) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ignyte Acquisition's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Ignyte Acquisition's accounts receivable are only considered to be worth 75% of book value:

Ignyte Acquisition's liquidation value for the quarter that ended in Jun. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.045	-	2.034	+	0.75 * 0	+	0.5 * 0
=	-1.99

Ignyte Acquisition Change In Receivables Related Terms

Thank you for viewing the detailed overview of Ignyte Acquisition's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Ignyte Acquisition (Ignyte Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Ignyte Acquisition Corp (NAS:IGNY) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

640 5th Avenue, 4th Floor, New York, NY, USA, 10019

Website

https://ignytespac.com

Ignyte Acquisition Corp is a blank check company.

Executives

Richard J Rosenstock	director	C/O GAINES BERLAND INC, 1055 STEWART AVENUE, BETHPAGE NY 11714
Cheryl Cohen	director	C/O MEDIVATION, INC., 201 SPEAR ST., 3RD FLOOR, SAN FRANCISCO CA 94105
Charles Wilson	director	C/O UNUM THERAPEUTICS, 200 CAMBRIDGEPARK DR., STE. 3100, CAMBRIDGE MA 02140
Ignyte Sponsor Llc	10 percent owner	640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
David I. Rosenberg	director, 10 percent owner, officer: Co-Chief Executive Officer	C/O IGNYTE ACQUISITION CORP., 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
John Andrew Boockvar	director	C/O IGNYTE ACQUISITION CORP., 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
David J. Strupp	director, 10 percent owner, officer: Co-Chief Executive Officer	107 DUNNING ROAD, NEW CANAAN CT 06840
Steven Neil Kaplan	director, officer: Chief Financial Officer	C/O IGNYTE ACQUISITION CORP., 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
Deerfield Management Company, L.p. (series C)	10 percent owner, other: Possible Member of 10% Group	345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p.	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Partners, L.p.	10 percent owner, other: Possible Member of 10% Group	345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
James E Flynn	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017